DBJP:ARCA-Deutsche X-trackers MSCI Japan Hedged Equity (USD)

ETF | Japan Stock | NYSE Arca

Last Closing

USD 74.66

Change

0.00 (0.00)%

Market Cap

USD 1.67B

Volume

3.00K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that correspond generally to the performance, of the MSCI Japan US Dollar Hedged Index. The fund, using a "passive" or indexing investment approach, seeks investment results that correspond generally to the performance, of the underlying index, which is designed to track the performance of the Japanese equity market while mitigating exposure to fluctuations between the value of the U.S. dollar and the Japanese yen. It will invest at least 80% of its total assets in component securities (including depositary receipts in respect of such securities) of the underlying index.

Inception Date: 09/06/2011

Primary Benchmark: MSCI Japan 100% hedged to USD NR USD

Primary Index: MSCI ACWI Ex USA NR USD

Gross Expense Ratio: 0.45%

Management Expense Ratio: 0.47 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-25 )

Largest Industry Peers for Japan Stock

Symbol Name Mer Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF 0.09 %

+0.32 (+1.13%)

USD 1.96B
FLJH Franklin FTSE Japan Hedged ETF 0.09 %

+0.54 (+1.73%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi.. 0.58 %

-0.55 (-0.73%)

N/A
DXJ WisdomTree Japan Hedged Equity.. 0.48 %

-0.88 (-0.79%)

N/A
EWJ iShares MSCI Japan ETF 0.47 %

+0.77 (+1.16%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap.. 0.25 %

+0.49 (+1.32%)

N/A
HEWJ iShares Currency Hedged MSCI J.. 0.01 %

+0.69 (+1.64%)

N/A
JPXN iShares JPX-Nikkei 400 ETF 0.48 %

+0.71 (+1.01%)

N/A
SCJ iShares MSCI Japan Small-Cap E.. 0.47 %

+0.56 (+0.77%)

N/A

ETFs Containing DBJP

CNDA Concord Acquisition Corp .. 0.00 % 0.70 %

N/A

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.34% 80% B- 77% C+
Dividend Return 3.41% 80% B- 51% F
Total Return 23.75% 80% B- 78% C+
Trailing 12 Months  
Capital Gain 20.57% 80% B- 79% B-
Dividend Return 3.42% 80% B- 50% F
Total Return 23.99% 80% B- 79% B-
Trailing 5 Years  
Capital Gain 72.74% 90% A- 81% B-
Dividend Return 18.63% 80% B- 61% D-
Total Return 91.38% 90% A- 83% B
Average Annual (5 Year Horizon)  
Capital Gain 16.48% 80% B- 77% C+
Dividend Return 19.44% 90% A- 78% C+
Total Return 2.96% 70% C- 63% D
Risk Return Profile  
Volatility (Standard Deviation) 14.91% 90% A- 67% D+
Risk Adjusted Return 130.41% 90% A- 99% N/A
Market Capitalization 1.67B 67% D+ 45% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.